| Title | Authors / Editors | Date |
unige:149341 |
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies |
Frisoni, Giovanni; Molinuevo, José Luis; Altomare, Daniele; Carrera, Emmanuel; ... Ritchie, Craig |
2020 |
unige:138781 |
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset |
Altomare, Daniele; Ferrari, Clarissa; Caroli, Anna; Galluzzi, Samantha; ... Frisoni, Giovanni |
2019 |
unige:138511 |
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study |
van Maurik, Ingrid S; Vos, Stephanie J; Bos, Isabelle; Bouwman, Femke H; ... van der Flier, Wiesje M |
2019 |
unige:138513 |
Applying the ATN scheme in a memory clinic population: The ABIDE project |
Altomare, Daniele; de Wilde, Arno; Ossenkoppele, Rik; Pelkmans, Wiesje; ... van der Flier, Wiesje M |
2019 |
unige:146823 |
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype |
Vermunt, Lisa; Sikkes, Sietske A M; van den Hout, Ardo; Handels, Ron; ... Visser, Pieter Jelle |
2019 |
unige:75906 |
Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression |
Caroli, Anna; Prestia, Annapaola; Galluzzi, Samantha; Ferrari, Clarissa; ... Frisoni, Giovanni |
2015 |
unige:106698 |
SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease |
Ramirez, Alfredo; van der Flier, Wiesje M; Herold, Christine; Ramonet, David |
2014 |
unige:149476 |
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease |
Prestia, Annapaola; Caroli, Anna; van der Flier, Wiesje M; Ossenkoppele, Rik; ... Frisoni, Giovanni |
2013 |